Global Times: How Guangxi snack 'snail rice noodles' becomes signature industry to fuel poverty reduction

Global Times: How Guangxi snack 'snail rice noodles' becomes signature industry to fuel poverty reduction

BEIJING, Feb. 17, 2025 /PRNewswire/ -- In the bustling alleys of Liuzhou, South China's Guangxi Zhuang Autonomous Region, the aroma of snail rice noodles, or Luosifen, wafts through the air, drawing locals and visitors alike into the myriad of shops...

NX Taiwan Becomes First Japanese Company to Receive QMS Certification for Medical Devices at Its NEXT3 Warehouse in Taoyuan City

NX Taiwan Becomes First Japanese Company to Receive QMS Certification for Medical Devices at Its NEXT3 Warehouse in Taoyuan City

TOKYO, Feb. 17, 2025 /PRNewswire/ -- Nippon Express (Taiwan) Co., Ltd. (hereafter "NX Taiwan"), a group company of NIPPON EXPRESS HOLDINGS, INC., obtained certification on Wednesday, December 18, 2024 from the Taiwan Food and Drug Administration...

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

OSR Holdings, Inc. to Begin Trading on the Nasdaq Stock Market LLC on Tuesday, February 18, 2025 Under the symbol "OSRH" SEOUL, South Korea, Feb. 15, 2025 /PRNewswire/ -- OSR Holdings, Inc. (formerly Bellevue Life Sciences Acquisition Corp. (the...

Full Truck Alliance Co. Ltd. to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on Wednesday, March 5, 2025

Full Truck Alliance Co. Ltd. to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on Wednesday, March 5, 2025

Earnings Call Scheduled for 7:00 A.M. U.S. ET on March 5, 2025 GUIYANG, China, Feb. 14, 2025 /PRNewswire/ -- Full Truck Alliance Co. Ltd. ("FTA" or the "Company") (NYSE: YMM), a leading digital freight platform, today announced that it will release...

Coway Announces Financial Results for Q4 and FY2024

Coway Announces Financial Results for Q4 and FY2024

Coway's 2024 Q4 revenue reached KRW 1,125.7 billion (+12.1% YoY) with an operating profit amounted to KRW 183.4 billion (+10.4% YoY) The company's FY2024 annual revenue totaled KRW 4,310.1 billion (+8.7% YoY) with an operating profit of KRW 795.4...

Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States

Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States

Hanmi Pharmaceutical Global Business Headquarters Accelerates Expansion into Canadian and US Markets, Strengthening Collaboration with Distribution Partner McKesson Introducing 'Countmate': A Customized Solution for Canadian and American Pharmacists...

Bellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc.

Bellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc.

SEOUL, South Korea, Feb. 14, 2025 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. ("BLAC") announced today the approval of each of the proposals presented at the special meeting of its stockholders (the "Special Meeting") held today,...

TOYO Co., Ltd to Participate in Upcoming Renewable Energy and Investment Conferences

TOYO Co., Ltd to Participate in Upcoming Renewable Energy and Investment Conferences

TOKYO, Feb. 13, 2025 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) ("TOYO" or the "Company"), a solar solution company, today announced its participation in upcoming industry and investment conferences in February and March 2025. CG Sustainability...

OneConnect Integrates DeepSeek into AI Agent Platform

OneConnect Integrates DeepSeek into AI Agent Platform

SHANGHAI, Feb. 13, 2025 /PRNewswire/ -- OneConnect Financial Technology Co., Ltd ("OneConnect" or the "Company", NYSE: OCFT, HKSE: 6638), a business technology service provider for financial institutions, launches its proprietary AI Agent Platform,...

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

SUZHOU, China, Feb. 13, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 biparatopic antibody-drug...

  • 1
  • ...
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • ...
  • 38
  • menu
    menu